Potential Role of Non-Steroidal Anti-Inflammatory Drugs in Colorectal Cancer Chemoprevention for Inflammatory Bowel Disease: An Umbrella Review
Inflammatory Bowel Disease (IBD) is a category of autoimmune diseases that targets the destruction of the gastrointestinal system and includes both Crohn’s Disease and Ulcerative Colitis (UC). Patients with IBD are at a higher risk of developing colorectal cancer (CRC) throughout their lives due to...
Main Authors: | Peri Newman, Joshua Muscat |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-02-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/15/4/1102 |
Similar Items
-
Non-Steroidal Anti-Inflammatory Drugs in Colorectal Cancer Chemoprevention
by: Jadwiga Maniewska, et al.
Published: (2021-02-01) -
Non-steroidal anti-inflammatory drugs and biomarkers: A new paradigm in colorectal cancer
by: Gowhar Rashid, et al.
Published: (2023-03-01) -
Chemoprevention of Colon Cancer by DFMO, Sulindac, and NO-Sulindac Administered Individually or in Combinations in F344 Rats
by: Venkateshwar Madka, et al.
Published: (2023-08-01) -
Nonsteroidal Anti-inflammatory Drugs for Chemoprevention in Patients With Familial Adenomatous Polyposis: A Systematic Review and Meta-Analysis
by: Umer Farooq, et al.
Published: (2023-01-01) -
Preclinical Cancer Chemoprevention Studies Using Animal Model of Inflammation-Associated Colorectal Carcinogenesis
by: Takuji Tanaka
Published: (2012-07-01)